RSSCategory: Genetics

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

Oncologists Say Genomic Testing Is Over Promoted Though It Is Likely To Be Useful Over The Next Decade

Fierce Healthcare (5/2, Sweeney) reports on a Medscape survey finding that among oncologists, about 70% “believe genetic testing is very important or extremely important to oncology, but 55% also say genomic testing is overpromoted.” One reason for that is that 89% believe “genomics will be useful in the next decade,” while just 64% “say it’s […]

Continue Reading

A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1

| April 3, 2017 | 3 Comments

A loyal reader tipped me off to a recent article in The New Yorker entitled “A.I. Versus M.D.” The article is written by Dr. Siddhartha Mukherjee, a well known oncologist and author of The Emperor of all Maladies. This article, the book and the documentary are all worth reading/viewing if you are not familiar with […]

Continue Reading

Leveraging Technology For Integrated Diagnostic Reporting

| March 9, 2017 | 0 Comments

By Chrystal Adams, Associate Vice President, XIFIN and Don Rule, CEO, Translational Software There is ongoing effort in healthcare to integrate and expand the use of patient data to improve clinical decision making and support cost-effective, patient-centered care. Much of the needed data resides within the diagnostic specialties of pathology, radiology, laboratory, and molecular diagnostics. […]

Continue Reading

Inspirata, a Silver Sponsor and Exhibitor at USCAP 2017 in San Antonio, to Demonstrate its New Digital Pathology Consultation Portal and Cockpit Features

| March 3, 2017 | 0 Comments

Stop by booth #310 to learn about Inspirata’s Cancer Diagnostics Workflow Solution, Precision Medicine Platform and International Consultation Portal. Tampa, FL, March 3, 2017/PRWeb – Cancer diagnostics workflow solution provider Inspirata, Inc. is a Silver sponsor and exhibitor at the upcoming USCAP 2017 in San Antonio March 6-8. As part of the expo, Inspirata will […]

Continue Reading

Trevor Heritage Joins Inspirata as Senior Vice President of Cancer Informatics

| February 21, 2017 | 0 Comments

Dr. Heritage is widely recognized for his work in the development of informatics systems for drug and performance chemical discovery, translational and personalized medicine, and pharmaceutical product development. San Francisco, CA, February 21, 2017  – Cancer diagnostics workflow solution provider Inspirata, Inc., is pleased to announce that Dr. Trevor Heritage has joined its executive team to […]

Continue Reading

‘Crosswalk’ Re-Launched to Make it Easier to Bridge the Gap Between Pathology, Precision Diagnosis and Precision Medicine

| February 20, 2017 | 1 Comment

Inspirata has just released new mobile and Web-based versions of “Crosswalk Insight: Oncology™,” a knowledge visualization platform that enables users to easily navigate through tumor images and the associated molecular pathways, targeted therapies and clinical trials. San Francisco, CA, February 20, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today the re-launch […]

Continue Reading

Epigenetics Changes Promote Pancreatic Cancer Metastasis

| January 20, 2017 | 0 Comments

Courtesy of Clinical OMICs – Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of pancreatic cancer cells. The results, published in the Nature Genetics article, “Epigenomic Reprogramming during Pancreatic Cancer Progression Links Anabolic Glucose Metabolism to Distant Metastasis,” […]

Continue Reading

Liquid Biopsies About to Get a Billion Dollar Boost

| January 18, 2017 | 0 Comments

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the cancer-detection startup Grail Bio’s are, it might not be enough. As CEO and […]

Continue Reading

Register Now for CAP Webinar on HER2 Testing in Gastroesophageal Adenocarcinoma

| January 13, 2017 | 0 Comments

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive advanced GEA. Because there are important differences in HER2 expression, scoring, and outcomes in GEA relative to breast carcinoma, the need for guideline recommendations […]

Continue Reading

ASCO, AMP and CAP Issue New Joint Consensus Statement to Standardize Interpretation and Reporting of Sequence Variants in Cancer

| January 3, 2017 | 0 Comments

Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was published online ahead of the January print issue of The Journal of Molecular Diagnostics. Thank you to a loyal reader for the […]

Continue Reading

Cancer Moonshot Initiative Grounded

| November 23, 2016 | 0 Comments

Previous posts on this matter referenced that even with the funding proposed in the hundreds of millions dollars (estimated $750 million proposal) a lot more would be required. I believe one critic I referenced said that even with that amount of funding, if approved, wouldn’t “get us off the ground” when it came to this […]

Continue Reading

Young Survival Coalition Expresses Concern About Overlooked Moonshot Recommedations

| September 30, 2016 | 0 Comments

I haven’t written much about the President’s Cancer Moonshot initiative recently and as much as I would like – perhaps because following some Blue Ribbon Panel recommendations and a large number of organizations and individuals expressing, in general, positive feedback among the cancer community, there hasn’t been a lot of news about next steps.  I […]

Continue Reading